Blood test could unlock why lung cancer drugs stop working
Knowledge-focused
Completed
This study aimed to understand why some lung cancers become resistant to targeted drugs. Researchers used a simple blood test, instead of a tissue biopsy, to look for genetic changes in 62 patients with ALK-positive lung cancer whose cancer had started growing again during treatm…
Sponsor: Addario Lung Cancer Medical Institute • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC